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Summary Insulin, glucagon, and insulin/glucagon 
mixtures have been infused for four days 
into the left portal vein of dogs after portacaval shunt. 
In the left but not the right liver lobes, insulin alone 
reduced atrophy, preserved hepatocyte ultrastructure, 
and trebled cell renewal. Glucagon alone had no effect. 
In small doses, glucagon did not potentiate the action of 
insulin and in large doses it may have reduced the insu-
lin benefit. These studies explain the development of the 
previously mysterious Eck fistula syndrome, provide 
clues about in-vivo cell growth control by hormones, and 
suggest new lines of inquiry about the pathogenesis 
and/or treatment of several human disease processes. 
Introduction 
A COMPLETELY divertlng portacaval shunt (Eck's fis-
tula) profoundly alters the structure and function of the 
liver in several species, I Until recently, these changes 
were thought 2- 6 in what has been termed the "flow 
hypothesis" to be caused by and to be proportionate to 
the reduction in total hepatic blood-flow which the pro-
cedure causes.· We have suggested instead that disrup-
tion of normal endogenous insulin delivery to the liver 
was mainly responsible7- 9 and in a preliminary com-
munication we showed that infusion of commercial insu-
lin into the tied-<>/f central portal vein of dogs prevented 
most of the acute atrophic changes that are ordinarily 
very advanced by light microscopy within four days 
after portacaval shunt. 10 
In this investigation, more complete studies were per-
formed in dogs of hormone infusions after Eck's fistula. 
Insulin, glucagon, and combinations of these two agents 
in various doses were tested for their effect upon the 
morphology and division-rates of the hepatocytes. 
Methods 
Anll:sthesia for operation and later killing was with sodium 
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pentobarbitone supplemented with phencyclidine hydro-
chloride ('Sernylan') and sucdiny1choline chloride ('Anectine' 1. 
Large side-to-side ponacaval shunts were constructed with 
excision of ellipses from both the portal vein and the inferior 
vena cava. The shunts were made completely divertmg by indi-
vidually ligating the main right and left portal trunks. Fre-
quent morning blood-sugars were determined during the 
period of study by means of an 'AutoAnalyzer'. 
The experimental groups of mongrel dogs are shown in table 
I. In groups 2-9, the tip of a fine infusion catheter was placed 
into the tied-{)tf left ponal branch and led through the body 
wall and through a long subcutaneous tunnel to a small calt-
brated finger pump that was incorporated into a light body 
cast (see accompanymg figure), The infusion volumes never 
exceeded 25 ml per day. Regular commercial insultn from beef 
and pork pancreas was used for much of the work. To rule out 
artefacts from contaminants, research-quality bovine insultn 
prepared by the Eli Lilly Company (indianapolis) was used in 
group 5 (lot no. 24C-3130). The glucagon which was pure 
(Lilly lot no. 95C-0314) came from beef and pork pancreas. 
The small and large glucagon infusion doses m the glucagon-
alone groups 6 and 7 respectively would have provided approx-
imately a 211 or 2/100 insulin/glucagon molar ratio had insu-
lin been given in the amounts used in groups 3 and 5. A 2/1 
ratio is in the physiological range. II 
Biopsy specimens were obtained from a left lobe at the time 
of ponacaval shunt (LO), and from left and right lobes (L4 
and R4) at the time of killing. About two hours before killing, 
63 of the 70 dogs were given 4·5 mC of (CH}_IH) thymidine 
by the intravenous route. The specific activity of the thymldme 
was 6·4 C per mmol. Because the same dose was alwavs used 
without regard to animal size, the dose spectrum pc;r kilo-
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gramme of body-weight was broad, ranging from 0·16 to 0·48 
mC. Shunt patency and catheter position were always verified 
a t necropsy. 
After fixation in formalin, frozen sections were cut from the 
samples of liver tissue and stained with sudan-4 for fat. The 
remaining tissue was then processed and the paraffin sections 
were stained by a variety of methods which have been de-
scribed previously.' 9 Autoradiography was carried out on 
paraffin sectlons using Kodak NTB2 liquid emulsion and an 
exposure-time of 28-35 days. Small cubes of each hepatic sam-
ple were used for electron microscopy. Initial fixation was glu-
taraldehyde followed by osmic acid. After embedding in 
'Epon', ultrathin sections were cut, stained with lead citrate, 
and exmined in a Philips 300 electron microscope. The size of 
the hepatocytes was determined by tracing out large number! 
of midzonalliver cells on standard-thickness paper, cutting out 
the silhouettes, and weighing them. The weights were referred 
to as size units. We have shown this to be an accurate method 
for comparing cell sizes by confirmatory planimetry and by 
studies of unicellular organisms, the size of which could be di-
rectly determined. Midzonal hepatocytes were also used for 
measuring on electron micrographs the length of rough endo-
plasmic reticulum per area of cytoplasm by Loud's method. ll 
Results 
Controls and Placebo Infusions 
Four days after portacaval shunt, the liver cell size 
units in both the left and right lobes of the animals of 
group 1 decreased by about half (table I). In addition to 
the hepatocyte shrinkage, light-microscopic examination 
showed that the hepatocytes were irregular in shape and 
were depleted of glycogen. The lobules were smaller 
than normal and the reticulin framework was condensed 
around the central veins. The Kupffer cells were 
enlarged and filled with material which included ceroid 
and lipofuscin and in three animals ha:mosiderin. A little 
fat was visible in the hepatocytes in 5 of the 11 dogs. 
The number of hepatocyte mitoses was greater than nor-
mal. 
The ultrastructural changes caused by Eck fistula 
within the four days were the same in the left and right 
lobes. The most prominent effects were decreases in the 
amount of rough endoplasmic reticulum with disruption 
and dilatation of the cisterna:. Morphometric analysis 
showed that the area of rough endoplasmIC reticulum 
per volume of cytoplasm was reduced to between half 
and a third the quantity found in the preoperative 
biopsy and the number of membrane-bound ribosomes 
was reduced. The quantity of smooth endoplasmic reti-
culum was increased. Some of the mitochondria were 
enlarged and showed distortion of their crista:. 
The autoradiographic studies gave quantitative con-
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firmation of the impression of an increased mitosis-rate 
(table II). The number of hepatocytes undergoing D.S.A. 
synthesis in both left and right liver lobes was nearly 5 
per 1000 (table Il). The rate in 17 normal dogs including 
6 that were subjected to sham dissections of the portal 
tract was recently established in our laboratories as 
1·6±O·4 (S.D.) per 1000 cells in the left lobes and 
1·6±O· 5 (S.D.) in the right lobes.9 
All of the foregoing findings were almost precisely the 
same in the dogs of group 2 whose left lobes were in-
fused with a heparin saline infusion for four days after 
Eck fistula (table I and II). 
Insulin Infusion 
The infusion of 0·43 units per kg/day of commercial 
insulin into the left portal vein for four days after Eck 
fistula in group-3 dogs markedly reduced the hepatocyte 
shrinkage in the left lobes without affecting at all the 
acute atrophy of the right lobar hepatocytes. The 
amount of glycogen in the cytoplasm of the hepatocytes 
in the left lobe was stiUless than normal, but much more 
than in the atrophic right lobar hepatocytes. The 
Kupffer cells in both lobes were enlarged and full of 
ceroid and lipofuscin. 
Cltrastructurally, comparisons of the left and right 
lobar hepatocytes showed that the liver cells exposed to 
insulin infusion were almost normal. The area of rough 
endoplasmic reticulum per volume of cytoplasm and the 
number of membrane-bound ribosomes were onlv 
slightly reduced; dilatation and disruption of the ci;-
tergDy~ were mmimal. Glycogen granules were frequent, 
but the number of small fat vacuoles was increased. The 
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changes in the hepatocytes in the right lobe did not 
differ from those seen in the controls. 
Autoradiography showed that in the insulin-infused 
left lobes the number of cells undergoing D.N.A. synthesis 
had nearly trebled whereas D.N.A.-synthesising cells in 
the right lobes of the group-3 dogs were not different in 
numbers from those in the untreated Eck fistula animals 
of groups 1 and 2. 
The results in all the end-points measured were 
almost exactly the same in the dogs of group 5 when 
purified insulin was used instead of the commercial insu-
lin (tables I and II). A pronounced but slightly reduced 
protective effect of the left lobes was still evident even 
when the insulin dose was reduced in group 4 to about 
a third of that used in groups 3 and 5 (tables I and II). 
In all the groups morning blood-sugars on frequent 
occasions did not deviate significantly from the normals 
in our laboratory (table 1/1). 
Glucagon Infusion 
The administration of small (group 6) and large 
(group 7) doses of glucagon into the left portal. vein for 
four days did not appreciably influence any of the 
changes caused by Eck fistula (tables 1 and II). 
Insulin/Glucagon Infusion 
When glucagon was added to proven effective doses of 
insulin to make an insulin/glucagon molar ratio of 2/1 
(group 8), the effect was no different than with insulin 
alone (tables I and II). 
The animals of group 9 received 100 times as much 
glucagon. Now the protection from hepatocyte atrophy 
in the left lobes afforded by insulin seemed partly lost. 
By one-way analysis of variance using Duncan's multi-
ple-range test with 95(/I confidence limits, the L4 hepato-
cytes were not in the same subset as in the protected 
groups 3, 5, and 8, but neither did they fit with the con-
trol and pure glucagon groups 1,2,6, and 7. The badly 
affected left lobar liver cells were still significantly less 
shrunken than those on the right (table I). The auto-
radiographic observations with D.N.A. incorporation 
showed the same threefold increase in the left lobes as 
with insulin alone or as with the 2/1 insulin/glucagon 
ratio ttable t1). 
The light and electron-microscopic analysis did not 
show why the insulin protection had been partly lost in 
group 9. The amount of glycogen in the left lobar hepa-
tocytes seemed almost normal, but the volume of rough 
endoplasmic reticulum was less than in the hepatocytes 
In the left lobes of dogs infused with insulin alone or in-
sulin combined with lower doses of glucagon. Some mito-
.:hondrial abnormalities were also present. 
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Discussion 
Eck thought 13 that a completely diverting portacaval 
shunt (Eck's fistula) in dogs was compatible with pro-
longed good health. This conclusion was refuted in 1893 
by Hahn, Massen, Rencki, and Pawlow 14 whose dogs 
with Eck fistula developed anorexia, weight loss, liver 
atrophy, and hepatic encephalopathy. The inability to 
explain these consequences caused Bollman IS to write in 
1961: "In the 83 years since it was first reported, the Eck 
fistula has been reasonabl,y successful in hiding its sec-
rets as well as in giving ris~ to many additional questions 
fundamental to an understanding of the functions of the 
intestine, liver, and brain." By then it had been widely 
accepted that the Eck fistula syndrome was caused by a 
suboptimal volume as opposed to quality of hepatic 
blood-flow. This conclusion had apparent support from 
the fact that the portoprival complications could be 
minimised if the central tied off portal vein was revascu-
larised with systemic venous blood (Child's portacaval 
transposition3) or with arterial blood. 
The flow concept was undermined by a series of inves-
tigations in which two canine livers or fragments of the 
same liver were given different kinds of portal in-
flow. 7- 9 16-20 The hepatocytes perfused with total portal 
flow or its pancreaticogastroduodenosplenic fraction 
became glycogen-rich, hypertrophic, and more active in 
cell renewal than the hepatocytes in the disadvantaged 
liver tissue which developed the histopathological fea-
tures caused by Eck fistula despite apparently adequate 
replacement flow. Collectively, the enriching consti-
tuents thus demonstrated to be in portal blood were 
called hepatotrophic substances. It became obvious from 
biochemical' 20 and pancreatectomv or alloxan-diabetes 
studies' 9 20 that insulin was the m~st important of these 
substances and that the well-known efficiency of insu-
lin's removal during a first pass through hepatic tis-
sue11 - n made it relatively unavailable for a second liver 
or liver fragment. At the same time the benefit after por-
tal diversion from flow augmentation procedures such as 
Child's portacaval transposition was explained. If insu-
lin and other hepatotrophic substances were bypassed 
around a single liver, they would be returned to it in 
diluted form in direct relation to the total hepatic blood-
flow. 
The natural deduction from our earlier studies was 
that many of the secrets of the Eck fistula were manifes-
tations of an altered hormone environment in which the 
most important change was deprivation of the liver of 
direct access to endogenous insulin. The experiments of 
a recent preliminary communication 10 and of this more 
complete report directly tested that hypothesis and with 
unequivocal results. 
Non-hypogJyca:mic insulin infusions for four days 
into the tied-off left portal vein after Eck fistula greatly 
reduced the left lobar hepatocyte atrophy, permitted the 
ultrastructure of the protected liver cells to remain 
essentially normal, and caused a threefold increase in 
the number of left lobar hepatocytes undergoing mitosis. 
There was no spillover effect in the right lobes. Gluca-
gon by itself did not cause any of these changes, and it 
did not potentiate them when added to insulin at a 2/1 
molar insulin/glucagon ratio. At a dose 100 times 
greater, glucagon may actually have reduced the benefit 
from insulin . 
Thus, it has been established that "hepatic insulino-
----------------------
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penia" is the most important element in the liver iniury 
of Eck fistula. It is ironic that this answer was so close 
to detection all the time. Hahn et al. 14 definitely empha-
sised more than 80 years ago that, unless the ponal vein 
was ligated above the last portal branch during the per-
formance of Eck fistula, their dogs remained quite nor-
mal. This highest vessel drains the pancreas, but of 
course the endocrinological significance of that fact was 
not then known. Because of that same ignorance of hor-
mones, speculation by Rous and Larimorel4 was vague 
about the possibility as they saw it in 1920 that ponal 
blood might have special liver-supporting constituents. 
A perplexing observation of our own from almost 20 
years ago contained a strong clueKl~ It was noticed that 
dogs with Eck fistula plus insulin-treated alloxan dia-
betes remained in much better health than animals with 
Eck fistula alone in that the diabetic dogs gained weight 
and were spared all evidence of encephalopathy. The 
now-obvious explanation is that peripheral insulin con-
centrations of two to three times normal are required in 
diabetics to maintain normoglyca:mia when insulin is 
given systemically,l6 thus inadvertently ·providing a 
compensatory hepatic arterial increase in the hormone. 
Conversely, in untreated alloxan-diabetic rats with unal-
tered hepatic circulation, Reaven, Peterson, and 
Reavenl7 have demonstrated acute ultrastructural 
changes in the liver cells that were remarkablv like those 
caused by Eck fistula. . 
In the past, we have emphasised7- 10 20 that multiple 
factors including collaborating hormones as well as nutri-
ents undoubtedly contribute to the total hepatotrophic 
effects of portal blood. It would be regrettable now 
if the very clarity with which insulin has emerged as a 
principal portal hepatotrophic substance were to obscure 
the search for contributory factors. The observation that 
the insulin protection in our experiments was not quite 
complete may be a reflection of missing ancillary sub-
stances although this could also be explained by the in-
ability of infusion pumps to make appropriate physi<r 
logical modulations of deliverv. 
However, it is particularly· in the area of cell growth 
control and regeneration that efforts must not be made 
to use insulin as a monolithic explanation for every-
thing.· This can be made clear with some observations 
about hepatocyte renewal under differing portoprival 
conditions. In livers of Eck fistula dogs of the present 
study, in rat livers after portacaval shunt,ll and in the 
portoprival hepatic fragments of double liver models8 • 
the atrophic and insulin-starved hepatocytes have been 
demonstrated by autoradiography to have mitosis-rates 
that paradoxicallv were three or four times normal. The 
stimulus for the iow-grade hYRCrplasia is unknown, but 
it is presumably a response to an increased hepatocyte 
death-rate. The provision of exogenous insulin in the 
present studies or of endogenous insulin in the compli-
cated double liver fragment experiments8 • provoked a 
sustained burst of proliferation bevond the already 
heightened mitotic background.· . 
These results were consistent with those in the impor-
tant study by Younger, King, and pteiner~9 who allowed 
rats to be alloxan-diabetic for a month before treallng 
them with insulin. Although the livers were thought to 
already contain a higher than normal number of hepat<r 
cytes, the proliferative response to insulin was spectacu-
lar, being similar to that after a 68(; liver resection. 
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However, Younger and his colleaguesl9 also showed that 
diabetic rats retained a potent although subnormal ab-
ility to regenerate their livers after an actual hepatic 
resection even if insulin treatment was withheld. 
Accordingly, it is unlikely that any single control factor 
will be the sole explanation of regeneration. HolleyJO 
and Leffert31 have summarised the dozens of substances, 
hormonal (including insulin) and others, that can in-
itiate and regulate cell growth in tissue-culture systems. 
There is no reason to doubt the relevance of their com-
ments concerning the complexities of growth control to 
in-vivo situations. 
Even so, the prospect seems promising of favourablv 
influencing regeneration and recovery after acute live~ 
injury in laboratory animals and ultimately in man by 
the simple expedient of intra portal insulin therapy. Ear-
lierB 10 we speculated that insulin for this purpose might 
have an augmented benefit if combined with glucagon. 
A recent study on regeneration by Bucher and Swaf-
field3l has provided suppon for such combination 
therapy. However, the failure in our studies reponed 
herein, as well as in past equally well-controlled 
ones,8 9 20 to identify a beneficial additive role of gluca-
gon, coupled with the slight possibility that in high doses 
it might have even cancelled some of the insulin benefit, 
would cause us either to omit glucagon or to use it in 
small amounts only. 
As such possibilities are considered, the relevance of 
canine portal physiology to man will be raised. It has 
been pointed out elsewhere l that the same general light 
and electron microscopic changes have now been seen 
after portal diversion in the livers of rats, dogs, baboons, 
and humans with some variations in degree. Thus, the 
hepatic injury of Eck fistula is common to all species so 
far studied. Fortunately, the most serious metabolic con-
sequences have seemed to selectively spare rats and man, 
a species difference that has made it feasible to perform 
the procedure with benefit to patients with glycogen-
storage diseaseH and homozygous type-II hyperlipid-
remia. J4 These applications accept a trade-off of distinctly 
suboptimal ·conditions of liver perfusion in return for 
metabolic improvements that almost certainly derive 
from the suboptimal conditions. lo II 34 A similar weigh-
ing of gains and losses is necessary for the traditional in-
dications for shunting operations in patients with 
a:sophageal varices who retain hepatopetal portal flow. 
An obvious argument can be mounted for a Warren-type 
operation which preserves much of the residual splanch-
nic flow to the liver including that returnmg from the 
pancreas. Jl 
Appreciation that there is a broader interplay between 
the liver and pancreas than the classical metabolic ones 
of ,\1adison 1b and Felig and \'\'ahr.:n J7 should have rami-
fications in understanding the complications of diabetes 
mellitus, the pathogenesis of liver disease, and numerous 
other clinical problems as has been pomted out by 
others.38 19 
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Summary Patients with disseminated melanoma 
were treated by repeated plasmapheresis 
using a continuous-flow blood-cell separator, as part of 
a study to investigate methods of removing factors from 
tissue fluids which block cell-mediated immunity. Using 
IICr release cytotoxic assays, it was found that plasma-
pheresis resulted in removal of serum blocking activity, 
Post-plasmapheresis sera taken from several patients 
also increased cell-mediated cytotoxicity by induction of 
antibody~ependent cell-mediated killing. This effect 
may have resulted from removal or alteration of circu-
lating immune complexes in the serum. It is not known 
whether cytotoxic activity induced in this way improves 
the patients' immune response against their tumours. 
However, the procedure is well tolerated and these pre-
liminary in-vitro results indicate that this form of 
therapy could act as an adjunct to other forms of treat-
ment of advanced melanoma. 
Introduction 
OBSERVATIONS in animal tumour models have sug-
gested that tumours can grow in hosts immune to the 
tumour because of the production of factors which in-
hibit the cell-mediated cytotoxic response of the host.l-5 
A similar explanation may account for progressive 
tumour growth in man.6- 9 Studies in human malignant 
meianoma lO II have shown a correlation between the 
clinical growth of melanoma and the presence or 
absence of serum blocking activity against cell-mediated 
cytoxicity (C.M.C.). 
We have attempted to determine whether removal of 
serum blocking activity of C.M.C. by plasmapheresis 
using a continuous-flow blood-cell separator would im-
prove the immune response of melanoma patIents 
against their tumours. 
Patients and Methods 
Patients 
Four patients were studied, all having evidence of dissemi-
nated melanoma characterISed by multiple subcutaneous 
nodules but no evidence of other visceral melastases as shown 
by clinical, radiological, or radionuclide scanning studics. 
Written consent was obtained from each patient. 
mltumaph~esis 
Plasmapheresis was carried out on an Ammco 'Ce1hrifuge' 
continuous-Row blood<ell separator with an average of 4 hires 
exchanged each time. Replacement fluids included physiolOgi-
cal saline, Hartmann's solution, hcal-trealed slable plasma-
prolein solution (s.p.p.s.) (Commonwealth Serum Labora-
tones, Melbourne), human serum albumin, or 'HEmaccel' 
